February 26, 2013

ASC-13-2



BC-13-3
MS-13-3

To:

All Blue Cross and Blue Shield of Kansas Contracting Providers

From:

Connie Winkley – Education/Communication Coordinator
Institutional Provider Relations
Blue Cross and Blue Shield of Kansas, Inc.
An Independent Licensee of the Blue Cross and Blue Shield Association

Subject:

DeNovo NT Natural Tissue Graft by Zimmer

Blue Cross and Blue Shield of Kansas (BCBSKS) considers the DeNovo NT Natural Tissue Graft by Zimmer to be considered experimental/ /investigational (E/I).

This determination was reached based on the following:

The DeNovo NT Graft Natural Tissue Graft is currently in a Clinical Trial  and is considered E/I.  BCBSKS recommends that the provider submits a signed Limited Patient Waiver (LPW) by the member if services, which are considered E/I, are provided to the member.

BCBSKS provides a medical policy on the Transplantation for Chondral Defects.  Click on the link to view the details of the medical policy.

If you have questions regarding this newsletter, please contact your BCBSKS Provider Representative.

Hospitals in Southern KS
Denny Hartman - 1-316-269-1602
Hospitals in Northern KS
Cindy Garrison - 1-785-291-8862
Ancillary Providers
Christie Blenden - 1-785-291-8813

 

cw